Income Statement Abbott India Limited

Equities

ABBOTINDIA

INE358A01014

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:46 07/07/2025 pm IST			5-day change	1st Jan Change
34,459.50 ^INR	-0.83%		-1.57%	+15.85%

15/05	Abbott India's quarterly profit climbs 28% on strong demand	RE
15/05	Abbott India Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025	CI

bc2b4b52f.yCbVKyjz1iV2NYF9lPak8H7oyWoBRBESGxDGDrC_X9Y.ilS3Qh-Gsk0iWfUS9rzoqTaNnV1rJVQ_eSCDaPiNO5GCTrtPHZrufDBg7g

Published financial data: ABBOTT INDIA LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	4.09TCr	4.31TCr	4.92TCr	5.35TCr	5.85TCr
Total Revenues	4.09TCr	4.31TCr	4.92TCr	5.35TCr	5.85TCr
Cost of Goods Sold, Total	2.33TCr	2.4TCr	2.67TCr	2.99TCr	3.23TCr
Gross Profit	1.77TCr	1.91TCr	2.25TCr	2.36TCr	2.62TCr
Selling General & Admin Expenses, Total	622.65Cr	612.61Cr	735.55Cr	685.45Cr	691.02Cr
Provision for Bad Debts	26.62L	-	-	-	-
Depreciation & Amortization - (IS)	60Cr	58Cr	66Cr	70Cr	71Cr
Other Operating Expenses	379.99Cr	371.67Cr	423.9Cr	467Cr	474.63Cr
Other Operating Expenses, Total	1.06TCr	1.04TCr	1.23TCr	1.22TCr	1.24TCr
Operating Income	705.47Cr	867.34Cr	1.03TCr	1.14TCr	1.38TCr
Interest Expense, Total	-6.13Cr	-15Cr	-15Cr	-12Cr	-8.88Cr
Interest And Investment Income	113.15Cr	80Cr	76Cr	144.06Cr	224Cr
Net Interest Expenses	107.03Cr	64Cr	61Cr	131.82Cr	215.12Cr
Currency Exchange Gains (Loss)	-8.08Cr	-3.76Cr	-4.16Cr	-4.31Cr	2.53Cr
Other Non Operating Income (Expenses)	-1.22Cr	-1.87Cr	-2.53Cr	-1.34Cr	88L
EBT, Excl. Unusual Items	803.21Cr	926.17Cr	1.08TCr	1.27TCr	1.6TCr
Gain (Loss) On Sale Of Assets	-55.67L	-25L	-	-26L	16L
Other Unusual Items	4L	3L	-	7.68Cr	20Cr
EBT, Incl. Unusual Items	802.69Cr	925.95Cr	1.08TCr	1.27TCr	1.62TCr
Income Tax Expense	209.76Cr	235.26Cr	281.03Cr	324.41Cr	416.53Cr
Earnings From Continuing Operations	592.93Cr	690.69Cr	798.7Cr	949.41Cr	1.2TCr
Net Income to Company	592.93Cr	690.69Cr	798.7Cr	949.41Cr	1.2TCr
Net Income - (IS)	592.93Cr	690.69Cr	798.7Cr	949.41Cr	1.2TCr
Net Income to Common Incl Extra Items	592.93Cr	690.69Cr	798.7Cr	949.41Cr	1.2TCr
Net Income to Common Excl. Extra Items	592.93Cr	690.69Cr	798.7Cr	949.41Cr	1.2TCr
Per Share Items
Net EPS - Basic	279.04	325.04	375.87	446.8	565.3
Basic EPS - Continuing Operations	279.04	325.04	375.87	446.8	565.3
Basic Weighted Average Shares Outstanding	2.12Cr	2.12Cr	2.12Cr	2.12Cr	2.12Cr
Net EPS - Diluted	279.04	325.04	375.87	446.8	565.3
Diluted EPS - Continuing Operations	279.04	325.04	375.87	446.8	565.3
Diluted Weighted Average Shares Outstanding	2.12Cr	2.12Cr	2.12Cr	2.12Cr	2.12Cr
Normalized Basic EPS	236.24	272.41	317.58	372.48	469.99
Normalized Diluted EPS	236.24	272.41	317.58	372.48	469.99
Dividend Per Share	107	120	145	180	410
Payout Ratio	17.92	32.92	31.93	32.45	31.84
Supplemental Items
EBITDA	721.75Cr	884.42Cr	1.05TCr	1.17TCr	1.41TCr
EBITA	705.65Cr	867.51Cr	1.03TCr	1.14TCr	1.38TCr
EBIT	705.47Cr	867.34Cr	1.03TCr	1.14TCr	1.38TCr
EBITDAR	721.93Cr	884.67Cr	1.05TCr	1.17TCr	1.41TCr
Total Revenues (As Reported)	4.21TCr	4.39TCr	5TCr	5.5TCr	6.1TCr
Effective Tax Rate - (Ratio)	26.13	25.41	26.03	25.47	25.75
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	208.28Cr	239.05Cr	281.16Cr	325.6Cr	415.43Cr
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	1.48Cr	-3.79Cr	-13L	-1.19Cr	1.07Cr
Normalized Net Income	502Cr	578.86Cr	674.83Cr	791.5Cr	998.71Cr
Interest on Long-Term Debt	5.9Cr	15Cr	15Cr	12Cr	8.67Cr
Non-Cash Pension Expense	78.56L	85L	41L	30L	-1.35Cr
Supplemental Operating Expense Items
Advertising Expense	146.36Cr	119.71Cr	155.77Cr	121.6Cr	114.14Cr
Selling and Marketing Expenses	146.36Cr	119.71Cr	155.77Cr	121.6Cr	114.14Cr
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	69L	84L	81L	79L	96L
Net Rental Expense, Total	18.11L	25L	32L	26L	30L
Imputed Operating Lease Interest Expense	-	18.64L	25.95L	19.22L	21.7L
Imputed Operating Lease Depreciation	-	6L	6L	7L	8L
Maintenance & Repair Expenses, Total	9.51Cr	9.36Cr	11Cr	11Cr	12Cr
Stock-Based Comp., SG&A Exp. (Total)	8.77Cr	9.75Cr	13Cr	12Cr	14Cr
Total Stock-Based Compensation	8.77Cr	9.75Cr	13Cr	12Cr	14Cr

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	145.14Cr	218.27Cr	132.71Cr	239.67Cr	291.74Cr
Short Term Investments	2.05TCr	2.18TCr	2.6TCr	1.68TCr	1.83TCr
Total Cash And Short Term Investments	2.19TCr	2.4TCr	2.74TCr	1.92TCr	2.12TCr
Accounts Receivable, Total	317.91Cr	250.21Cr	288.16Cr	316.95Cr	319.11Cr
Other Receivables	129.84Cr	116.64Cr	100.45Cr	94Cr	124.69Cr
Notes Receivable	6.14Cr	4.95Cr	-	-	-
Total Receivables	453.9Cr	371.8Cr	388.61Cr	411.39Cr	443.8Cr
Inventory	527.17Cr	717.59Cr	687.82Cr	648.85Cr	619.58Cr
Prepaid Expenses	5.64Cr	5.78Cr	6.97Cr	6.73Cr	9.01Cr
Restricted Cash	3.41Cr	6.44Cr	9.3Cr	11Cr	13Cr
Other Current Assets, Total	23Cr	16Cr	25Cr	24Cr	42Cr
Total Current Assets	3.2TCr	3.52TCr	3.85TCr	3.03TCr	3.25TCr
Gross Property Plant And Equipment	382.59Cr	334.01Cr	366.83Cr	354.62Cr	374.64Cr
Accumulated Depreciation	-112.02Cr	-84Cr	-103.8Cr	-121.57Cr	-146.25Cr
Net Property Plant And Equipment	270.57Cr	250.27Cr	263.03Cr	233.05Cr	228.39Cr
Long-term Investments	-	-	-	1.14TCr	1.51TCr
Other Intangibles, Total	89.87L	1.17Cr	8.63Cr	7.52Cr	6.66Cr
Loans Receivable Long-Term	17Cr	14Cr	-	-	-
Deferred Tax Assets Long-Term	14Cr	18Cr	17Cr	17Cr	16Cr
Other Long-Term Assets, Total	40Cr	38Cr	82Cr	135.9Cr	190.75Cr
Total Assets	3.55TCr	3.84TCr	4.22TCr	4.56TCr	5.19TCr
Liabilities
Accounts Payable, Total	657.77Cr	762.67Cr	889.45Cr	891.99Cr	1TCr
Accrued Expenses, Total	100.74Cr	98Cr	133.8Cr	120.83Cr	125.71Cr
Current Portion of Leases	36Cr	35Cr	43Cr	46Cr	46Cr
Current Income Taxes Payable	7.64Cr	15Cr	12Cr	11Cr	11Cr
Unearned Revenue Current, Total	5.01Cr	6.04Cr	4.07Cr	4.71Cr	7.4Cr
Other Current Liabilities	84Cr	113.44Cr	121.06Cr	132.27Cr	148.99Cr
Total Current Liabilities	891.1Cr	1.03TCr	1.2TCr	1.21TCr	1.34TCr
Long-Term Leases	139.2Cr	117.68Cr	108.74Cr	67Cr	37Cr
Pension & Other Post Retirement Benefits	4.87Cr	5.06Cr	3.24Cr	2.63Cr	3.19Cr
Other Non Current Liabilities	80Cr	85Cr	89Cr	91Cr	111.93Cr
Total Liabilities	1.12TCr	1.24TCr	1.4TCr	1.37TCr	1.49TCr
Common Stock, Total	21Cr	21Cr	21Cr	21Cr	21Cr
Retained Earnings	2.38TCr	2.54TCr	2.75TCr	3.12TCr	3.63TCr
Comprehensive Income and Other	33Cr	43Cr	45Cr	47Cr	45Cr
Total Common Equity	2.43TCr	2.6TCr	2.82TCr	3.19TCr	3.7TCr
Total Equity	2.43TCr	2.6TCr	2.82TCr	3.19TCr	3.7TCr
Total Liabilities And Equity	3.55TCr	3.84TCr	4.22TCr	4.56TCr	5.19TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.12Cr	2.12Cr	2.12Cr	2.12Cr	2.12Cr
ECS Total Common Shares Outstanding	2.12Cr	2.12Cr	2.12Cr	2.12Cr	2.12Cr
Book Value / Share	1.14T	1.22T	1.33T	1.5T	1.74T
Tangible Book Value	2.43TCr	2.6TCr	2.81TCr	3.18TCr	3.69TCr
Tangible Book Value Per Share	1.14T	1.22T	1.32T	1.5T	1.74T
Total Debt	174.89Cr	152.58Cr	151.69Cr	113.17Cr	83Cr
Net Debt	-2.02TCr	-2.25TCr	-2.58TCr	-1.81TCr	-2.03TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	8.79Cr	2.42Cr	6L	42L	4.47Cr
Debt Equivalent Oper. Leases	1.45Cr	2Cr	2.56Cr	2.08Cr	2.4Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	78Cr	164.14Cr	112.09Cr	139.21Cr	117.67Cr
Inventories - Work In Process, Total	21Cr	18Cr	9.34Cr	15Cr	18Cr
Inventories - Finished Goods, Total	428.92Cr	535.6Cr	566.39Cr	494.36Cr	484.15Cr
Inventories - Others	-	-	-	-	-
Land - (BS)	37.55L	38L	-	-	-
Buildings, Total	51Cr	52Cr	54Cr	55Cr	61Cr
Machinery, Total	117.6Cr	133.75Cr	171.85Cr	195.61Cr	231.86Cr
Full Time Employees	3.55T	3.58T	3.6T	3.7T	3.81T
Accumulated Allowance for Doubtful Accounts (Supple)	11Cr	12Cr	13Cr	12Cr	14Cr

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	592.93Cr	690.69Cr	798.7Cr	949.41Cr	1.2TCr
Depreciation & Amortization - CF	57Cr	56Cr	65Cr	69Cr	70Cr
Amortization of Goodwill and Intangible Assets - (CF)	17.42L	17L	81L	91L	85L
Depreciation & Amortization, Total	58Cr	57Cr	66Cr	70Cr	71Cr
Amortization of Deferred Charges, Total - (CF)	77.79L	49L	38L	37L	39L
(Gain) Loss From Sale Of Asset	55.67L	25L	-	26L	-16L
Stock-Based Compensation (CF)	8.77Cr	9.75Cr	13Cr	12Cr	14Cr
Provision and Write-off of Bad Debts	38.7L	2.8Cr	1.22Cr	-9L	1.39Cr
Other Operating Activities, Total	-104.66Cr	-45Cr	-60Cr	-161.51Cr	-204.26Cr
Change In Accounts Receivable	-42Cr	65Cr	-39Cr	-29Cr	-1.68Cr
Change In Inventories	80Cr	-190.42Cr	30Cr	39Cr	29Cr
Change In Accounts Payable	-8.51Cr	108.94Cr	115.12Cr	-1.41Cr	96Cr
Change in Other Net Operating Assets	41Cr	28Cr	23Cr	14Cr	5.85Cr
Cash from Operations	626.11Cr	726.74Cr	947.66Cr	893.39Cr	1.21TCr
Capital Expenditure	-16Cr	-23Cr	-44Cr	-34Cr	-48Cr
Sale of Property, Plant, and Equipment	17.17L	13L	23L	48L	20L
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-505.97Cr	-135.12Cr	-420.99Cr	-216.32Cr	-511.53Cr
Other Investing Activities, Total	120.33Cr	86Cr	69Cr	102.24Cr	143.63Cr
Cash from Investing	-401.19Cr	-72Cr	-395.84Cr	-147.71Cr	-416.03Cr
Long-Term Debt Repaid, Total	-50Cr	-50Cr	-52Cr	-54Cr	-54Cr
Total Debt Repaid	-50Cr	-50Cr	-52Cr	-54Cr	-54Cr
Common Dividends Paid	-106.25Cr	-227.37Cr	-255Cr	-308.11Cr	-382.49Cr
Common & Preferred Stock Dividends Paid	-106.25Cr	-227.37Cr	-255Cr	-308.11Cr	-382.49Cr
Special Dividend Paid	-32Cr	-303.86Cr	-329.36Cr	-276.25Cr	-308.11Cr
Other Financing Activities, Total	-29Cr	-51L	-70L	-49L	-20L
Cash from Financing	-216.79Cr	-581.79Cr	-637.38Cr	-638.72Cr	-744.71Cr
Net Change in Cash	8.13Cr	73Cr	-86Cr	106.96Cr	52Cr
Supplemental Items
Cash Interest Paid	22.6L	51L	70L	49L	20L
Cash Income Tax Paid (Refund)	257.56Cr	235.46Cr	288.99Cr	340.86Cr	404.47Cr
Levered Free Cash Flow	556.03Cr	611.31Cr	802.76Cr	768.32Cr	1TCr
Unlevered Free Cash Flow	559.86Cr	620.85Cr	812.4Cr	775.97Cr	1.01TCr
Change In Net Working Capital	-68Cr	-35Cr	-136.33Cr	-15Cr	-110.77Cr
Net Debt Issued / Repaid	-50Cr	-50Cr	-52Cr	-54Cr	-54Cr

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	13.59	14.68	15.9	16.23	17.69
Return on Total Capital	19.11	20.22	22.39	22.72	24.34
Return On Equity %	26.71	27.44	29.46	31.6	34.88
Return on Common Equity	26.71	27.44	29.46	31.6	34.88
Margin Analysis
Gross Profit Margin %	43.19	44.31	45.77	44.17	44.73
SG&A Margin	15.21	14.21	14.95	12.82	11.81
EBITDA Margin %	17.63	20.52	21.3	21.79	24.05
EBITA Margin %	17.24	20.13	20.87	21.33	23.6
EBIT Margin %	17.24	20.12	20.85	21.32	23.58
Income From Continuing Operations Margin %	14.49	16.03	16.24	17.75	20.54
Net Income Margin %	14.49	16.03	16.24	17.75	20.54
Net Avail. For Common Margin %	14.49	16.03	16.24	17.75	20.54
Normalized Net Income Margin	12.26	13.43	13.72	14.8	17.08
Levered Free Cash Flow Margin	13.58	14.18	16.32	14.36	17.17
Unlevered Free Cash Flow Margin	13.68	14.4	16.51	14.51	17.26
Asset Turnover
Asset Turnover	1.26	1.17	1.22	1.22	1.2
Fixed Assets Turnover	21.86	16.55	19.17	21.56	25.35
Receivables Turnover (Average Receivables)	13.78	15.17	18.27	17.68	18.34
Inventory Turnover (Average Inventory)	4.1	3.86	3.8	4.47	5.1
Short Term Liquidity
Current Ratio	3.6	3.41	3.2	2.51	2.42
Quick Ratio	2.96	2.68	2.6	1.94	1.91
Operating Cash Flow to Current Liabilities	0.7	0.7	0.79	0.74	0.9
Days Sales Outstanding (Average Receivables)	26.56	24.06	19.97	20.65	19.96
Days Outstanding Inventory (Average Inventory)	89.25	94.64	96.14	81.69	71.8
Average Days Payable Outstanding	107.68	100.06	114.29	110.32	108.24
Cash Conversion Cycle (Average Days)	8.13	18.64	1.82	-7.98	-16.47
Long Term Solvency
Total Debt/Equity	7.19	5.86	5.38	3.55	2.25
Total Debt / Total Capital	6.71	5.54	5.1	3.43	2.2
LT Debt/Equity	5.72	4.52	3.86	2.12	0.99
Long-Term Debt / Total Capital	5.34	4.27	3.66	2.04	0.97
Total Liabilities / Total Assets	31.44	32.24	33.25	30.01	28.78
EBIT / Interest Expense	115.18	56.84	66.52	93.16	155.34
EBITDA / Interest Expense	124.57	60.54	70.78	98.84	163.31
(EBITDA - Capex) / Interest Expense	122	59.02	67.93	96.06	157.87
Total Debt / EBITDA	0.23	0.17	0.14	0.09	0.06
Net Debt / EBITDA	-2.64	-2.43	-2.37	-1.5	-1.4
Total Debt / (EBITDA - Capex)	0.23	0.17	0.14	0.1	0.06
Net Debt / (EBITDA - Capex)	-2.7	-2.5	-2.47	-1.54	-1.45
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	11.27	5.3	14.14	8.86	9.35
Gross Profit, 1 Yr. Growth %	11.82	8.02	17.89	5.22	10.73
EBITDA, 1 Yr. Growth %	18.66	22.54	18.45	11.89	21.64
EBITA, 1 Yr. Growth %	19.11	22.94	18.34	11.81	21.93
EBIT, 1 Yr. Growth %	19.12	22.94	18.27	11.81	21.95
Earnings From Cont. Operations, 1 Yr. Growth %	31.67	16.49	15.64	18.87	26.52
Net Income, 1 Yr. Growth %	31.67	16.49	15.64	18.87	26.52
Normalized Net Income, 1 Yr. Growth %	16.54	15.31	16.58	17.8	26.23
Diluted EPS Before Extra, 1 Yr. Growth %	31.67	16.49	15.64	18.87	26.52
Accounts Receivable, 1 Yr. Growth %	15.14	-21.3	15.17	9.99	0.1
Inventory, 1 Yr. Growth %	-13.12	36.12	-4.15	-5.67	-4.51
Net Property, Plant and Equip., 1 Yr. Growth %	160.56	-7.5	5.1	-11.4	-2
Total Assets, 1 Yr. Growth %	20.6	8.28	9.99	7.85	14
Tangible Book Value, 1 Yr. Growth %	21.13	7	8.08	13.16	16.07
Common Equity, 1 Yr. Growth %	21.07	7.01	8.36	13.08	16.01
Cash From Operations, 1 Yr. Growth %	25.44	16.07	30.4	-5.73	35.75
Capital Expenditures, 1 Yr. Growth %	27.75	48.09	89.06	-22.6	41.69
Levered Free Cash Flow, 1 Yr. Growth %	-24.01	9.94	25.32	-3.84	31.69
Unlevered Free Cash Flow, 1 Yr. Growth %	-23.5	10.89	24.96	-4.04	31.1
Dividend Per Share, 1 Yr. Growth %	114	12.15	20.83	24.14	127.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.4	8.24	9.63	11.4	9.11
Gross Profit, 2 Yr. CAGR %	12.93	9.9	12.84	11.23	7.94
EBITDA, 2 Yr. CAGR %	16.83	20.59	20.48	14.8	16.2
EBITA, 2 Yr. CAGR %	17.14	21.01	20.62	14.69	16.29
EBIT, 2 Yr. CAGR %	17.2	21.02	20.58	14.66	16.3
Earnings From Cont. Operations, 2 Yr. CAGR %	21.57	23.84	16.06	17.24	22.64
Net Income, 2 Yr. CAGR %	21.57	23.84	16.06	17.24	22.64
Normalized Net Income, 2 Yr. CAGR %	13.66	15.92	15.94	16.93	21.92
Diluted EPS Before Extra, 2 Yr. CAGR %	21.57	23.84	16.06	17.24	22.64
Accounts Receivable, 2 Yr. CAGR %	9.85	-4.81	-4.79	12.55	5.23
Inventory, 2 Yr. CAGR %	-5.1	8.75	14.23	-4.91	-5.09
Net Property, Plant and Equip., 2 Yr. CAGR %	83.05	55.25	-1.4	-3.5	-6.82
Total Assets, 2 Yr. CAGR %	21.16	14.27	9.13	8.91	10.88
Tangible Book Value, 2 Yr. CAGR %	19.93	13.85	7.54	10.59	14.6
Common Equity, 2 Yr. CAGR %	19.86	13.82	7.68	10.7	14.53
Cash From Operations, 2 Yr. CAGR %	102.49	20.67	23.03	10.87	13.13
Capital Expenditures, 2 Yr. CAGR %	-3.07	37.59	67.33	20.97	4.72
Levered Free Cash Flow, 2 Yr. CAGR %	388.89	-8.6	20.16	9.52	12.11
Unlevered Free Cash Flow, 2 Yr. CAGR %	403.36	-7.9	20.46	9.25	11.75
Dividend Per Share, 2 Yr. CAGR %	46.29	54.92	16.41	22.47	68.15
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.14	9.33	10.17	9.33	10.71
Gross Profit, 3 Yr. CAGR %	14.34	11.27	12.5	10.15	11.06
EBITDA, 3 Yr. CAGR %	21.63	18.7	19.87	17.32	16.73
EBITA, 3 Yr. CAGR %	22.28	19.04	20.11	17.38	16.74
EBIT, 3 Yr. CAGR %	22.27	19.08	20.09	17.36	16.73
Earnings From Cont. Operations, 3 Yr. CAGR %	28.93	19.85	21.05	16.99	20.26
Net Income, 3 Yr. CAGR %	28.93	19.85	21.05	16.99	20.26
Normalized Net Income, 3 Yr. CAGR %	22.52	14.21	16.14	16.39	19.94
Diluted EPS Before Extra, 3 Yr. CAGR %	28.93	19.85	21.05	16.99	20.26
Accounts Receivable, 3 Yr. CAGR %	21.74	-1.7	1.43	-0.1	8.45
Inventory, 3 Yr. CAGR %	1.74	7.03	4.27	7.17	-4.78
Net Property, Plant and Equip., 3 Yr. CAGR %	33.86	45.8	36.32	-4.85	-3
Total Assets, 3 Yr. CAGR %	19.74	16.7	12.83	8.7	10.58
Tangible Book Value, 3 Yr. CAGR %	20.66	15.46	11.89	9.38	12.39
Common Equity, 3 Yr. CAGR %	20.58	15.41	11.97	9.45	12.44
Cash From Operations, 3 Yr. CAGR %	26.78	68.21	23.83	12.58	18.61
Capital Expenditures, 3 Yr. CAGR %	-8.69	11.66	52.96	29.41	27.51
Levered Free Cash Flow, 3 Yr. CAGR %	23.06	197.3	3.14	11.38	16.17
Unlevered Free Cash Flow, 3 Yr. CAGR %	23.34	204.01	3.54	11.49	15.81
Dividend Per Share, 3 Yr. CAGR %	38.82	33.89	42.6	18.93	50.61
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.32	10.51	11.13	10.15	9.72
Gross Profit, 5 Yr. CAGR %	12.79	11.37	13.74	11.25	10.6
EBITDA, 5 Yr. CAGR %	17.82	19.24	21.17	17.13	18.25
EBITA, 5 Yr. CAGR %	18.34	19.66	21.61	17.28	18.43
EBIT, 5 Yr. CAGR %	18.33	19.66	21.59	17.29	18.42
Earnings From Cont. Operations, 5 Yr. CAGR %	20.96	22.03	23.62	18.8	21.68
Net Income, 5 Yr. CAGR %	20.96	22.03	23.62	18.8	21.68
Normalized Net Income, 5 Yr. CAGR %	18.57	18.39	19.85	15.29	18.32
Diluted EPS Before Extra, 5 Yr. CAGR %	20.96	22.03	23.62	18.8	21.68
Accounts Receivable, 5 Yr. CAGR %	19.25	11.08	10.34	3.77	2.94
Inventory, 5 Yr. CAGR %	6.21	14.16	6.56	2.08	0.42
Net Property, Plant and Equip., 5 Yr. CAGR %	23.01	18.35	18.45	23.61	17.07
Total Assets, 5 Yr. CAGR %	20.89	18.89	15.38	13.52	12.05
Tangible Book Value, 5 Yr. CAGR %	21.09	16.89	15.23	13.48	12.97
Common Equity, 5 Yr. CAGR %	21	16.83	15.25	13.5	12.99
Cash From Operations, 5 Yr. CAGR %	23.86	23.92	25.27	42.38	19.43
Capital Expenditures, 5 Yr. CAGR %	-2.73	0.51	16.36	15.29	31.45
Levered Free Cash Flow, 5 Yr. CAGR %	19.43	29.07	21.89	101.27	6.54
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.56	29.39	22.18	103.75	6.65
Dividend Per Share, 5 Yr. CAGR %	28.12	27.94	29.38	29.2	52.32